MG

Martin Glen

Investment Director at GripAble

Greater London, England

Overview 

Martin Glen is an Investment Director at Parkwalk Advisors and serves as a Director at Cytora, PsyOmics, Gripable, and Wayland Additive in Greater London, England. With a background in investment management and hedge funds, he has made significant investments in companies like Psyomics, Wayland Additive, and Gripable, focusing on sectors such as diagnostics, chemicals, and digital health. Martin Glen's career highlights include his role as a Partner at Cheyne Capital and his experience as an Analyst/Portfolio Manager at Meditor, showcasing a strong background in equity research, asset management, and alternative investments.

Work Experience 

M-Spin

  • Director

    2024 - Current

G

GripAble

  • Investment Director

    2022

    Gripable is developing a digital platform for rehabilitation, gamifying exercises with novel devices, gathering data for monitoring and optimising treatment, helping patients, service providers and healthcare payors by increasing efficiency and generating superior outcomes.

PA

Parkwalk Advisors

  • Investment Director

    2016

    Parkwalk Advisors (www.parkwalkadvisors.com) is a leading technology growth EIS investment manager. We focus on UK university spin-out companies, largely in knowledge intensive, 'hard' science. Meet and engage with some amazing people and their brilliant ideas that will hopefully continue to support UK plc and change the world through the next few decades.

WA

Wayland Additive

  • Non Executive Director

    2021

PL

PSYOMICS LTD

  • Director

    2017

C

Cytora

  • Director

    2017

Charco Neurotech

  • Non Executive Director

    2021 - 2024

CC

Cheyne Capital

  • Partner

    2014 - 2015

    European equity portfolio management, especially Industrials, and the IPO market in a special situations fund

Meditor

  • Analyst/Portfolio Manager

    2005 - 2014

    Nine years managing the deal desk at Meditor. Analysing IPOs and follow-on offerings across all sectors and all geographies from a fundamental perspective. Dealing in chosen investments and forming excellent relationships with syndicate/ECM departments at counterparties. Involved in the process from pre-IPO / pilot fishing all the way to aftermarket trading.

Jefferies Europe

  • Analyst/sales

    2003 - 2005

    An attempt at sales, firstly specialist sales for UK & European pharmaceutical analysts and then a more generalised salesman for the European small and midcap product. Not very successful though it made me much more tolerant of those who do sell!

Education 

Investments 

Psyomics

Series A

Total funding: $11M

Koalaa

Seed

Total funding: $1M

Wayland Additive

Series A

Total funding: $11M

Gripable

Series A

Total funding: $11M

Articles About Martin

Relevant Websites